Glycogen and Glycosylation: Friends or Foes?
Biomolecules · 16.06.2026 · 16 (6) · 885
DOI: 10.3390/biom16060885 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 16.06.2026. Verfasst von Rohit Sai Reddy Konada und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Neurology, UT Southwestern Medical Center, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Glycogen, Glycogen Storage Disease. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Health.
Abstract (Originalsprache)
Glycosylation, glycogen metabolism, and ubiquitination represent three fundamental cellular processes that are traditionally studied as distinct aspects of biology. Glycosylation and glycogen metabolism are unique carbohydrate-based pathways. The process of glycosylation generates structurally diverse glycans that regulate protein folding, cell signaling, and host–pathogen interactions, while glycogen serves as a glucose reserve essential for energy homeostasis. Emerging evidence reveals a deep mechanistic connection between these pathways, particularly in the context of brain biology and inherited metabolic diseases. Here, we present recent research linking glycosylation defects with glycogen metabolism, highlighting how changes in the shared metabolites and enzymatic pathways contribute to human health and disease. We then discuss the overlapping disease symptoms of congenital disorders of glycosylation and glycogen storage diseases, with particular emphasis on polyglucosan body-forming diseases. We also highlight the role of non-canonical ubiquitin ligase complexes such as laforin–malin and LUBAC and present emerging evidence for their potential role in the glycogen quality-control mechanism. Finally, we review current therapeutic strategies for CDGs and GSDs, including monosaccharide supplementation, glycogen synthase modulation, and gene therapy. Together, this review underscores glycogen as more than an energy store—as a key contributor to glycosylation homeostasis and cellular regulation in health and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Neurology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Biochemistry, UT Southwestern Medical Center, Dallas, TX 75390, USA.
ORCID-Profile: Rohit Sai Reddy Konada, Sharmistha Mitra
Förderung
- NINDS NIH HHS
- National Institute of Health
Zitieren
APA
Konada, R. S. R., Osborn, J., & Mitra, S. (2026). Glycogen and Glycosylation: Friends or Foes?. Biomolecules, 16(6), 885. https://doi.org/10.3390/biom16060885
Vancouver
Konada RSR, Osborn J, Mitra S. Glycogen and Glycosylation: Friends or Foes?. Biomolecules. 2026;16(6):885. doi:10.3390/biom16060885
BibTeX
@article{Konada2026,
author = {Konada, Rohit Sai Reddy and Osborn, James and Mitra, Sharmistha},
title = {Glycogen and Glycosylation: Friends or Foes?},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {6},
pages = {885},
doi = {10.3390/biom16060885}
}
EUVIMED